Molecule

Lucent

This company provides a platform for biopharmaceutical firms to tokenise drug intellectual property and royalties for retail investors to purchase.

Bio.xyz

Bio.xyz provides a decentralized science launchpad and AI-driven tools for biotech organisations and research communities to fund and commercialise scientific intellectual property.

Deip

This company provides a protocol for tokenising and governing intangible assets to help creators, researchers and inventors monetise their intellectual property.

Drug Discovery

This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Molecular Glue Labs

This company develops artificial intelligence software and infrastructure to design small-molecule drugs that reprogram protein networks to treat previously untreatable diseases.

Diffuse Bio

This company develops generative artificial intelligence software and experimental screening platforms for protein design and validation for pharmaceutical and biotechnology researchers.

Cime Therapeutics

The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.